• Users Online: 108
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2020  |  Volume : 8  |  Issue : 2  |  Page : 61-66

De-escalation Strategies in Human Papilloma Virus-Positive Oropharyngeal Cancer


Department of Head and Neck/Plastic Reconstructive Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Correspondence Address:
Vishal Gupta
Department of Head and Neck/Plastic Reconstructive Surgery, Roswell Park Comprehensive Cancer Center, Elm and Cartlon Streets, Buffalo, NY 14263
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jhnps.jhnps_29_20

Rights and Permissions

Human papilloma virus (HPV) is now attributable to most of the oropharyngeal squamous cell cancers (OPSCCs) occurring in western world. The HPV-associated OPSCC effect younger, otherwise healthy population and is typically associated with better outcome. Traditional treatment strategies, while successful, are associated with significant long-term morbidity and poorer quality of life. This has led to various trials and investigations to de-escalate the treatment in this patient population while maintaining excellent outcome. The objective of this review is to discuss various de-escalation strategies and trials.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed306    
    Printed10    
    Emailed0    
    PDF Downloaded43    
    Comments [Add]    

Recommend this journal